Monday, January 11, 2016

Pfizer CEO: Drug pricing a political issue

Insight to the regulatory process of pricing drugs, with Ian Read, Pfizer Chairman and CEO.

from Mergers and Acquisitions http://ift.tt/1RxG4Sb

No comments:

Post a Comment